# Azurity Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/azurity-pharmaceuticals-inc/be6c2042-21df-4e44-a30d-11c6629303d8

> Inspection records and compliance data for Azurity Pharmaceuticals, Inc. in Wilmington, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Azurity Pharmaceuticals, Inc.
- FEI Number: 3003395329
- City: Wilmington
- State: Massachusetts
- Country Name: United States
- Address Line 1: 841 Woburn St
- Zip Code: 01887

## Related Documents

- [FDA Inspection 1297348 - Azurity Pharmaceuticals, Inc. - 2025-12-12](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/624df1ea-7a53-4a00-8c3c-afb7e077a0e8) — source: FDA, date: December 12, 2025
- [FDA Inspection 1297348 - Azurity Pharmaceuticals, Inc. - 2025-12-12](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/7c93bd99-060c-47b1-906c-ce6cdfe7bf52) — classification: No Action Indicated (NAI), source: FDA, date: December 12, 2025
- [483 - Azurity Pharmaceuticals, Inc. - 2025-02-19](https://www.keypedia.com/records/483/azurity-pharmaceuticals-inc/fbd8eaca-fe0a-415e-8722-8c80ddd8f442) — source: FDA, date: February 19, 2025
- [FDA Inspection 1261303 - Azurity Pharmaceuticals, Inc. - 2025-02-19](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/5bc3e1cb-551b-4b19-8657-c5a1e0e2c087) — source: FDA, date: February 19, 2025
- [483 - Azurity Pharmaceuticals, Inc. - 2023-03-02](https://www.keypedia.com/records/483/azurity-pharmaceuticals-inc/3a26f0be-61a2-41f0-9deb-51eead2d9a04) — source: FDA, date: March 2, 2023
- [483 - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.keypedia.com/records/483/azurity-pharmaceuticals-inc/2704437d-fff0-4d09-b5aa-59c63a5d39d3) — source: FDA, date: February 24, 2022
- [FDA Inspection 1163010 - Azurity Pharmaceuticals, Inc. - 2022-02-24](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/12a62341-3a2c-4ccd-af8a-ac1ef6bbb9ad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2022
- [483 - Azurity Pharmaceuticals, Inc. - 2020-01-15](https://www.keypedia.com/records/483/azurity-pharmaceuticals-inc/5112db17-449d-4ac7-802d-0dd69b3bd25b) — source: FDA, date: January 15, 2020
- [FDA Inspection 1100022 - Azurity Pharmaceuticals, Inc. - 2019-07-26](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/824bff13-d825-4069-b07d-12705e842fb0) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2019
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/406cc9d4-18de-434c-8f96-b6a0e230e396) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/d7596e4b-a5e0-4350-8e79-09c75eb1d79a) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 970690 - Azurity Pharmaceuticals, Inc. - 2016-04-19](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/5756e04c-0ea5-484f-8186-33c970bbf441) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2016
- [FDA Inspection 865746 - Azurity Pharmaceuticals, Inc. - 2014-01-29](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/c7e3a821-6edb-412a-9b64-4239d82e6a03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2014
- [FDA Inspection 865746 - Azurity Pharmaceuticals, Inc. - 2014-01-29](https://www.keypedia.com/records/fda_inspections/azurity-pharmaceuticals-inc/ddf3c586-cea3-4b42-a9a0-2c62a45dff9b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2014

## Related Companies

- [Transdermal Cap Inc.](https://www.keypedia.com/companies/transdermal-cap-inc/04de6863-f166-4f39-af50-2e3af20c851d)
- [Nestle Purina Pet Care Co.](https://www.keypedia.com/companies/nestle-purina-pet-care-co/3761fd9c-f9c7-4946-abfa-ffb31c4ad494)
- [Maquet SAS](https://www.keypedia.com/companies/maquet-sas/7e2d533e-d7fc-4715-b60c-928657757140)
- [Specialty Vision Llc](https://www.keypedia.com/companies/specialty-vision-llc/0c61d4ea-8225-445f-8273-7f0d3c9bf6b4)
- [Global Vitality Inc.](https://www.keypedia.com/companies/global-vitality-inc/54edd927-fab0-4bd7-b4ba-010315a54817)
- [Hi-Tech Pharmaceuticals Inc.](https://www.keypedia.com/companies/hi-tech-pharmaceuticals-inc/f2be5f4c-a707-4de1-9243-b03b9120bdf7)
- [Inspire Medical Systems Inc.](https://www.keypedia.com/companies/inspire-medical-systems-inc/c8cf6ad9-b74a-4b39-83c9-5d6cfbdb4676)
- [KEDPlasma, LLC](https://www.keypedia.com/companies/kedplasma-llc/f2a2a9ec-e43c-4fdd-aa9c-fedb8df93507)
- [National Advanced Endoscopy Devices Inc](https://www.keypedia.com/companies/national-advanced-endoscopy-devices-inc/06acc5d3-a599-4eab-8af9-7f21f65bb4ea)
- [HRF, Inc](https://www.keypedia.com/companies/hrf-inc/869e77e4-8d06-4ddb-890f-c1fe550ae080)

## Related Officers

- [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Investigator](https://www.keypedia.com/people/terry-bridgewater/59dfea35-4435-47b1-ac4a-0eb6eaf83bc8)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)